Avenue - Avelumab in the frontline treatment of advanced classic Hodgkin Lymphoma - a window study
Authors
Booth, S.Hawkes, E.
Kirkwood, A. A.
Barrington, S. F.
Medd, P. G.
McKay, P.
Pettengell, R.
Iyengar, S.
Miall, F.
Radford, John A
Burton, C.
Sud, A.
Shah, N.
Scott, A. M.
Ardavan, A.
Northend, M.
Clifton-Hadley, L.
Jenner, R.
Collins, G. P.
Affiliation
Department of Haematology, Oxford University Hospitals, Oxford, United KingdomIssue Date
2021
Metadata
Show full item recordCitation
Booth S, Hawkes E, Kirkwood AA, Barrington SF, Medd PG, McKay P, et al. Avenue - Avelumab in the Frontline Treatment of Advanced Classic Hodgkin Lymphoma - a Window Study. Blood. 2021 Nov;138. PubMed PMID: WOS:000736413901199.Journal
BloodDOI
10.1182/blood-2021-145189Additional Links
https://dx.doi.org/10.1182/blood-2021-145189Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/blood-2021-145189